Rocket Lab USA, Inc. (RKLB) experienced a pre-market plunge of 5.05% on Friday, as multiple negative factors converged to pressure the stock.

The decline was driven primarily by ongoing dilution concerns stemming from the company's previously filed plan to issue up to $3 billion in common stock, with recent regulatory filings indicating newly issued shares are entering market circulation. Additionally, a Form 4 filing revealed that SVP and General Counsel Arjun Kampani sold approximately 88,668 shares between May 26-27, which the market may interpret as a negative short-term signal despite the transactions being described as tax-related sell-to-cover sales.

Broader sentiment in the space sector also contributed to the weakness, following a Blue Origin rocket explosion that raised concerns about the space stocks boom and prompted profit-taking across the industry after recent strong gains.